ROC analysis showed that MMP7 serum levels clearly distinguished both IPF and CTD-ILD patients from healthy controls in our study, thus making them a promising biomarker to differentiate between ILD patients and healthy controls. This evidence concerns the gene MMP7 and idiopathic pulmonary fibrosis.